RAYONIER ADVANCED MATERIALS INC. current report, 07 August 2017

Business Context and Reporting Period

Company: Rayonier Advanced Materials Inc.
Filing Type: Form 8-K (Current Report)
Date: August 7, 2017
Subject: Regulatory approval for the proposed acquisition of Tembec Inc. via a plan of arrangement.

Key Financial Metrics

This filing is a regulatory update regarding a merger and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.

Material Changes and Transaction Status

  • Quebec Superior Court Approval: The court issued an order approving the plan of arrangement, satisfying a key condition for the acquisition of all outstanding common shares of Tembec Inc.
  • Regulatory Clearances Received:
    • Germany's Federal Cartel Office.
    • United States Department of Justice and Federal Trade Commission (Hart-Scott-Rodino waiting period terminated).
  • Pending Approvals: Applications for clearance are pending in Canada and China.
  • Anticipated Closing: Subject to remaining conditions, the transaction is expected to close in the fourth quarter of 2017.

Guidance, Outlook, and Risks

Outlook: Management anticipates completion of the Arrangement in Q4 2017, contingent upon final regulatory approvals and satisfaction of closing conditions.

Risks and Contingencies:

  • Failure to satisfy conditions to the transaction.
  • Failure to close on expected terms.
  • Uncertainty regarding the timing of closing and receipt of third-party approvals.

Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to risks and uncertainties.

Investor Verification Checklist

  • Confirm the status of pending regulatory approvals in Canada and China.
  • Monitor for any additional closing conditions that may arise prior to the anticipated Q4 2017 completion.
  • Review the full text of the joint press release (Exhibit 99.1) for specific deal terms and financial implications not detailed in this 8-K summary.